Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Mallinckrodt
Covington
Cerilliant
Novartis
Queensland Health
Baxter
Cipla
Teva
UBS

Generated: February 23, 2018

DrugPatentWatch Database Preview

AZACTAM Drug Profile

« Back to Dashboard

When do Azactam patents expire, and what generic alternatives are available?

Azactam is a drug marketed by Bristol Myers Squibb and is included in two NDAs.

The generic ingredient in AZACTAM is aztreonam. There are eight drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the aztreonam profile page.
Drug patent expirations by year for AZACTAM
Pharmacology for AZACTAM
Ingredient-typeMonobactams
Drug ClassMonobactam Antibacterial
Medical Subject Heading (MeSH) Categories for AZACTAM

US Patents and Regulatory Information for AZACTAM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bristol Myers Squibb AZACTAM aztreonam INJECTABLE;INJECTION 050580-002 Dec 31, 1986 AP RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Bristol Myers Squibb AZACTAM IN PLASTIC CONTAINER aztreonam INJECTABLE;INJECTION 050632-003 May 24, 1989 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Bristol Myers Squibb AZACTAM aztreonam INJECTABLE;INJECTION 050580-003 Dec 31, 1986 AP RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Bristol Myers Squibb AZACTAM aztreonam INJECTABLE;INJECTION 050580-001 Dec 31, 1986 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Bristol Myers Squibb AZACTAM IN PLASTIC CONTAINER aztreonam INJECTABLE;INJECTION 050632-001 May 24, 1989 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Bristol Myers Squibb AZACTAM IN PLASTIC CONTAINER aztreonam INJECTABLE;INJECTION 050632-002 May 24, 1989 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Merck
Accenture
Cantor Fitzgerald
AstraZeneca
Federal Trade Commission
US Department of Justice
Covington
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot